A clinical trial of PAT DX1
Latest Information Update: 18 Dec 2023
At a glance
- Drugs PAT DX1 (Primary)
- Indications Cancer
- Focus Adverse reactions; First in man
- 14 Dec 2023 According to a Patrys media release, company will initiate this first-in-human clinical trial of PAT-DX1 in the second half of CY 2024.
- 24 Apr 2023 According to a Patrys media release, company is expecting to initiate this trial in calendar year 2024 due to sporadic issue in the most recent production run of clinical grade PAT-DX1.
- 09 Mar 2023 According to a Patrys media release, the company is currently talking to Contract Research Organisations (CROs) to run the clinical trial.